Pretoria, 21 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) is aware of a quality issue in a batch of YAZ Plus contraceptives (Batch No. WEW96J distributed on 09 and 24 November 2023) which has resulted in the incorrect arrangement of tablets...
Pretoria, 13 April 2024 – On 10 April 2024, the South African Health Products Regulatory Authority (SAHPRA) received a report from the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) regarding the detection of high levels of diethylene glycol in a batch...
The South African Health Products Regulatory Authority (SAHPRA) is commemorating the #MedSafetyWeek2023 campaign, in collaboration with South African Pharmacy Council (SAPC), by hosting a webinar focused on the Importance of Reporting Adverse Events. The #MedSafetyWeek is an international social media campaign organised every year by the Uppsala Monitoring...
The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA) hosted an engagement with Inspection Bodies. We have invited several Inspection Bodies to share their knowledge, experience, and expertise to begin this conversation focusing on the: Accreditation process by the South African National Accreditation...
The South African Health Products Regulatory Authority (SAHPRA) hosted a conversation on what medication errors are and why it is vital that patients or healthcare professionals report them. We have invited panellists from two hospitals to share their knowledge, experience, and expertise to begin this important...
23 April 2021 Post Importation Testing Exemptions (PITE) granted due to COVID-19 pandemic Post importation testing exemption approvals granted since March 2020 due to the Covid-19 pandemic, are extended to 30 September 2021 without further need of an application thereof. The initial approval date was extended to...
22 April 2021 SAHPRA is pleased to announce the launch of the Med Safety App. The Med Safety App is a mobile application (App) that is designed to simplify and promote the reporting of suspected adverse drug reactions (ADRs), including adverse events following immunisation (AEFIs) by...
30 March 2020 In line with the recommendation of the South African National Institute for Communicable Disease (NICD) and the recommendation of the World Health Organization (WHO), SAHPRA wishes to point out that the so-called Rapid test kits (serological test kits) that are being offered...
The document in the link below has been prepared to serve as a guideline to healthcare professionals, reporting adverse drug reactions and product quality problems. It represents South African Health Products Regulatory Authority’s (SAHPRA’s) current thinking on the safety, quality and efficacy of medicines (including...
